Jonathan Licht – PI

Jonathan D. Licht, MD, is the Director of the University of Florida Health Cancer Center, holding the Marshall E. Rinker, Sr. Foundation and David B. and Leighan R. Rinker Chair. Previously Dr. Licht was Chief of Hematology/Oncology at Northwestern University and an Associate Director of the Robert H. Lurie Comprehensive Cancer Center.

Dr. Licht’s laboratory studies aberrant gene regulation, specifically the role of abnormal function of histone methyl transferases and histone demethylases in diseases such as multiple myeloma and is developing small molecule strategies to normalize gene regulation and treat disease.

NCI funded for nearly 25 years, Dr. Licht is also Principal Investigator of a Leukemia and Lymphoma Society Specialized Center and a Multiple Myeloma Research Foundation program grant, both in epigenetics. He is an investigator in the Dana-Farber SPORE in myeloma and co-leader in a NCI-funded Chicago Region Physical Sciences Oncology Center. Dr. Licht just completed a 10 year term as Senior Editor of Clinical Cancer Research and is currently an Associate Editor of Oncogene and serves on the editorial board of Cancer Cell and Cancer Research. Dr. Licht is a member of the executive committee of the American Society of Hematology, and will be co-director of the 2017 ASH/EHA Translational Research Training program. Additionally he sits on the Medical/Scientific Board of the Leukemia and Lymphoma Society and is a member of the NIH Basic Mechanisms of Cancer Therapeutics Study Section.

Dr. Licht has published nearly 170 original articles, reviews and book chapters. Dr. Licht has mentored over 40 graduate students and postdoctoral fellows and 20 faculty members.

Education: MD – Columbia University

Postdoc: Dana-Farber Cancer Institute, Harvard Medical School